Adesão à terapêutica em doentes diabéticos tipo 2: estudo de caso numa farmácia em Almada

Dissertação de Mestrado, Ciências Farmacêuticas, Faculdade de Ciências e Tecnologia, Universidade do Algarve, 2016

Evaluation of antibiotic prescription for upper respiratory tract infections in the community pharmacy setting

This is an Open access article distributed under the terms of Creative Commons Attribution 4.0 International License. http://creativecommons.org/licenses/by/4.0/

Diferencia de daños por herbívoros entre hojas jóvenes de color rojo y verde, ¿podría tratarse de mimetismo vegetal?

La presencia de coloración roja en las hojas jóvenes de algunas especies vegetales en los bosques tropicales podría servir como una señal para los herbívoros de la presencia de defensas químicas en las mismas, que tendría como consecuencia el escape al daño por los herbívoros. Los objetivos específicos de este trabajo fueron comparar entre hojas jóvenes verdes y rojas: a) los niveles de daño por herbívoros, b) la dureza y c) la aceptabilidad de tejido vegetal por herbívoros generalistas (saltamontes Vellea mexicana). Las hojas jóvenes rojas presentaron significativamente menor daño por herbívoros que las hojas jóvenes verdes; la dureza fue también significativamente menor en las hojas jóvenes rojas, mientras que la aceptabilidad de follaje por herbívoros no mostró diferencia significativa entre los dos tipos de hojas. Se sugiere que la coloración roja podría representar una estrategia efectiva de baja inversión de recursos que estaría permitiendo a las vulnerables hojas jóvenes escapar al daño causado por los herbívoros.

Community pharmacists’ understanding, attitudes, practice and perceived barriers related to providing pharmaceutical care: a questionnaire-based survey in Macao

Purpose: To explore the knowledge, attitudes, practice and perceived barriers of community pharmacists regarding provision of pharmaceutical care as well as provide recommendations on how to advance the service during the early stage of development in Macao. Methods: A questionnaire comprising 10 items was used to collect respondents’ demographic information and to evaluate their understanding of pharmaceutical care, attitude towards service provision, current practice and perceived barriers. Descriptive and comparative analysis of the results was conducted. Results: While 95 % of the participating pharmacists agreed that patients’ health was their primary responsibility, only 57 % believed that they can provide better pharmaceutical care in the future. The majority spent most of their work time counselling patients (90 %) and checking prescription (70 %). Only a small portion monitored adverse drug reaction and drug compliance (44 %), engaged in health screening or drug safety promotion (20 %) or maintained patient medication records (4 %). Insufficient communication with physicians (90 %), lack of time (79 %) and lack of physical space at the pharmacy (76 %) were considered the most significant barriers. Conclusion: A suboptimal level of pharmaceutical care is provided by pharmacists in Macao. Considering the barriers identified and integrating other country experiences, establishing an enabling atmosphere using policy and regulatory measures is the fundamental element for advancing pharmaceutical care by community pharmacists.

Influence of pharmacists expertise on physicians prescription decisions

Purpose: To explore the influence of pharmacist factors on prescription decisions of physicians. Methods: A survey of literature was carried out across online databases and 12 relevant articles were identified. The influence of pharmacist factors on physician prescription decisions was identified in the articles. A conceptual model for investigating pharmacist factors that influence physicians’ prescription decisions was then developed. Results: The main factors identified were pharmacist expertise, pharmacist – physician collaboration, and trust between physician and pharmacist. There was no direct evidence of influence of pharmacist expertise on prescription, but some studies indicated that pharmacist recommendation is in tandem with the prescribing behaviour of physicians. One study reported that pharmacist–physician collaboration positively influenced physicians’ prescribing decision, while others found no relationship between these. Conclusion: Existing literature on the influence of pharmacist factors on prescription behaviour of physicians are limited and debatable. There is no consistency in these studies. Moreover, studies that reported a strong connection between the trustworthiness and pharmacist–physician collaboration in drug prescription lack hard evidence.

Cartographie récente et écologie du nerprun bourdaine en Estrie

Le nerprun bourdaine (Rhamnus frangula L.) est une espèce exotique qui envahit plusieurs régions du sud du Québec, et plus particulièrement la région administrative de l'Estrie. Actuellement, on connaît encore peu l'écologie de l'espèce dans le contexte québécois et il n’existe pas de portrait d’ensemble de sa distribution dans les forêts tempérées de cette région. Dans ce contexte, le premier objectif du projet était de cartographier par télédétection la distribution du nerprun bourdaine dans deux secteurs de l'Estrie. Un second objectif était d'évaluer les variables environnementales déterminantes pour expliquer le recouvrement de nerprun bourdaine. La phénologie du nerprun bourdaine diffère de celle de la plupart des espèces indigènes arborescentes puisque ses feuilles tombent plus tard en automne. Cette caractéristique a permis de cartographier, par démixage spectral, la probabilité d'occurrence du nerprun bourdaine grâce à une série temporelle d'images du capteur OLI de Landsat 8. Le recouvrement du nerprun bourdaine a été calculé dans 119 placettes sur le terrain. La cartographie résultante a montré un accord de 69% avec les données terrain. Une image SPOT-7, dont la résolution spatiale est plus fine, a ensuite été utilisée, mais n’a pas permis d'améliorer la cartographie, puisque la date d’acquisition de l’image n’était pas optimale dû à un manque de disponibilité. Concernant le second objectif de la recherche, la variable la plus significative pour expliquer la présence de nerprun bourdaine était la densité du peuplement, ce qui suggère que l’ouverture de la couverture forestière pourrait favoriser l’envahissement. Néanmoins, les résultats tendent à démontrer que le nerprun bourdaine est une espèce «généraliste» qui s’adapte bien à plusieurs conditions environnementales.

A retrospective study examining the nature, contributory factors and predictors of dispensing errors in community pharmacy

Introduction: Since 2005, the workload of community pharmacists in England has increased with a concomitant increase in stress and work pressure. However, it is unclear how these factors are impacting on the ability of community pharmacists to ensure accuracy during the dispensing process. This research seeks to extend our understanding of the nature, outcome, and predictors of dispensing errors. Methodology: A retrospective analysis of a purposive sample of incident report forms (IRFs) from the database of a pharmacist indemnity insurance provider was conducted. Data collected included; type of error, degree of harm caused, pharmacy and pharmacist demographics, and possible contributory factors. Results: In total, 339 files from UK community pharmacies were retrieved from the database. The files dated from June 2006 to November 2011. Incorrect item (45.1%, n = 153/339) followed by incorrect strength (24.5%, n = 83/339) were the most common forms of error. Almost half (41.6%, n = 147/339) of the patients suffered some form of harm ranging from minor harm (26.7%, n = 87/339) to death (0.3%, n = 1/339). Insufficient staff (51.6%, n = 175/339), similar packaging (40.7%, n = 138/339) and the pharmacy being busier than normal (39.5%, n = 134/339) were identified as key contributory factors. Cross-tabular analysis against the final accuracy check variable revealed significant association between the pharmacy location (P < 0.024), dispensary layout (P < 0.025), insufficient staff (P < 0.019), and busier than normal (P < 0.005) variables. Conclusion: The results provide an overview of some of the individual, organisational and technical factors at play at the time of a dispensing error and highlight the need to examine further the relationships between these factors and dispensing error occurrence.

The role of pharmacists in caring for young people with chronic illness

Purpose - To explore the perceived and potential roles of pharmacists in the care of young people aged 10-24 years with chronic illness, through the exemplar of juvenile arthritis, from the perspectives of UK community and hospital pharmacists, health service commissioners, rheumatology health professionals and lay advocates. Methods - A sequential mixed methods study design comprising: focus groups with community and hospital pharmacists; telephone interviews with pharmacy and rheumatology stakeholders and commissioners, and multidisciplinary group discussions to prioritize roles generated by the first two qualitative phases. Results - The high priority roles for pharmacists, identified by pharmacists and rheumatology staff, were: developing generic healthcare skills among young people; transferring information effectively across care interfaces; building trusting relationships with young people; helping young people to find credible online health information, and the need to develop specialist expertise. Participants identified associated challenges for pharmacists in supporting young people with chronic illness. These challenges included parents collecting prescription refills alone, thus reducing opportunities to engage, and pharmacist isolation from the wider healthcare team. Conclusions - This study has led to the identification of specific enhancements to pharmacy services for young people which have received the endorsement of a wide range of stakeholders. These suggestions could inform the next steps in developing the contribution of community and hospital pharmacy to support young people with chronic illness in the optimal use of their medication.

Cartographie récente et écologie du nerprun bourdaine en Estrie

Le nerprun bourdaine (Rhamnus frangula L.) est une espèce exotique qui envahit plusieurs régions du sud du Québec, et plus particulièrement la région administrative de l'Estrie. Actuellement, on connaît encore peu l'écologie de l'espèce dans le contexte québécois et il n’existe pas de portrait d’ensemble de sa distribution dans les forêts tempérées de cette région. Dans ce contexte, le premier objectif du projet était de cartographier par télédétection la distribution du nerprun bourdaine dans deux secteurs de l'Estrie. Un second objectif était d'évaluer les variables environnementales déterminantes pour expliquer le recouvrement de nerprun bourdaine. La phénologie du nerprun bourdaine diffère de celle de la plupart des espèces indigènes arborescentes puisque ses feuilles tombent plus tard en automne. Cette caractéristique a permis de cartographier, par démixage spectral, la probabilité d'occurrence du nerprun bourdaine grâce à une série temporelle d'images du capteur OLI de Landsat 8. Le recouvrement du nerprun bourdaine a été calculé dans 119 placettes sur le terrain. La cartographie résultante a montré un accord de 69% avec les données terrain. Une image SPOT-7, dont la résolution spatiale est plus fine, a ensuite été utilisée, mais n’a pas permis d'améliorer la cartographie, puisque la date d’acquisition de l’image n’était pas optimale dû à un manque de disponibilité. Concernant le second objectif de la recherche, la variable la plus significative pour expliquer la présence de nerprun bourdaine était la densité du peuplement, ce qui suggère que l’ouverture de la couverture forestière pourrait favoriser l’envahissement. Néanmoins, les résultats tendent à démontrer que le nerprun bourdaine est une espèce «généraliste» qui s’adapte bien à plusieurs conditions environnementales.

Feeding ecology and life-history strategy of nesting males in a fish with long parental care, Lusitanian toadfish (Halobatrachus didactylus, Batrachoididae)

The Lusitanian toadfish, Halobatrachus didactylus, like other batrachoidids, is a benthic fish species with nesting behaviour during the breeding season. During this prolonged period it engages in mating activities and remains in the nest providing parental care. It is not known whether males feed while providing parental care but it is likely that their limited mobility may restrict their diet and influence their fitness. As a consequence, egg cannibalism could occur as a life-history strategy. The aim of the present study is to ascertain the feeding behaviour of nesting males, in comparison to mature non-nesting males, and to identify potential life-history traits related to egg cannibalism. Nest-holders were sampled from artificial nests placed in an intertidal area of the Tagus estuary, only exposed during spring low tides. The diet of nest-holders was compared with that of non-nesting mature males from the same area, captured by otter trawl. The present study demonstrates that despite their constrained mobility nest-holders feed during the breeding season, although in a more opportunistic fashion than non-nesting males. Nest-holders showed a generalist feeding behaviour, with a more heterogeneous diet. Egg cannibalism was not related to male condition, paternity or brood size but showed a higher incidence early in the season when water temperatures were lower. The results suggest a possible seasonal trade-off strategy between care and energy recovery, triggered by environmental factors, where under unfavourable conditions to sustain viable eggs the male may recover energy by eating eggs, thus benefiting future reproductive success, later in the season.

Economic evaluations of clinical pharmacy services in Ireland, 2007-2015

Introduction The concept of this thesis was driven by stagnation within the Irish healthcare system. Multiple reports from pharmacy organisations had outlined possible future directions for the profession but progress was minimal, especially in comparison with other countries. The author’s directive was to evaluate the economic impact of a series of clinical pharmacy services (CPS) in hospital and community settings. Methods A systematic review of economic evaluations of clinical pharmacy services in hospital patients was undertaken to gain insight into recent research in the field. Eligible studies were evaluated using the Consolidated Health Economic Evaluation Reporting Standards (CHEERS), to establish the quality, consistency and transparency of relevant research. A retrospective analysis of an internal hospital pharmacy interventions database was conducted. A method first described by Nesbit et al. was implemented to estimate the level of cost avoidance achieved. A cost-effectiveness analysis based on data from a randomised controlled trial of a pharmacist-supervised patient self-testing (PST) of warfarin therapy is presented. Outcome measure was the incremental cost associated with six months of intervention management. A similar cost-effectiveness analysis based on previously published RCT data was used to evaluate a novel structured pharmacist review of medication in older hospitalised patients. Cost-effectiveness analysis was presented in the form of an incremental cost-effectiveness ratio (ICER). An ICER is an additional cost per unit effect, in the case of this study, the cost of preventing an additional non-trivial ADR in hospital. A method described by Preaud et al. was adapted to estimate the clinical and economic benefit gained from vaccination of patients by a community pharmacist in Ireland in 2013/14. Sample demographic data was obtained from a national chain of community pharmacies and applied to overall national vaccination data. Results Systematic review identified twenty studies which were eligible for inclusion. Overall, pharmacist interventions had a positive impact on hospital budgets. Only three studies (15%) were deemed to be “good-quality” studies. No ‘novel’ clinical pharmacist intervention was identified during the course of this review. Analysis of internal hospital database identified 4,257 interventions documented on 2,147 individual patients over a 12 month period. Substantial cost avoidance of €710,000 was generated over a 1 year period from the perspective of the health care provider. Mean cost avoidance of €166 per intervention was generated. The cost of providing these interventions was €82,000. Substantial net cost-benefits of €626,279 and a cost-benefit ratio of 8.64 : 1 were generated based on this evaluation of pharmacist interventions. Results from an evaluation of a novel pharmacist-led form of warfarin management indicated indicated that on a per patient basis, PST was slightly more expensive than established anticoagulant management. On a per patient basis over a six month period, PST resulted in an incremental cost of €59.08 in comparison with routine care. Overall cost of managing a patient through pharmacist-supervised PST for a six month period is €226.45. However, for this increase in cost a clinically significant improvement in care was provided. Patients achieved a significantly higher time in therapeutic range during the PST arm in comparison with routine care, (72 ± 19.7% vs 59 ± 13.5%). Difference in overall cost was minimal and PST was the dominant strategy in some scenarios examined during sensitivity analysis. Structured pharmacist review of medication was determined to be dominant in comparison to usual pharmaceutical care. Even if the healthcare payer was unwilling to pay any money for the prevention of an ADR, the intervention strategy is still likely to be cost-effective (probability of being determined cost-effective = 0.707). Implementation of pharmacist-led influenza vaccination has resulted in substantial clinical and economic benefits to the healthcare system. The majority of patients (64.9%) who availed of this service had identifiable influenza-related risk factors. Of patients with influenza-related risk factors, age ≥65 year was the most commonly cited risk factor. Pharmacist vaccination services averted a total of 848 influenza cases across all age groups during the 2013/2014 influenza season. Due to receipt of vaccination in a pharmacy setting, 444 influenza-related GP visits were prevented. In terms of more serious influenza-associated events, 11 hospitalisations and five influenza-related deaths were averted. Costs averted were approximately €305,000. These were principally wider societal-related costs associated with lost productivity. Conclusion Overall, clinical pharmacy services are adding value to the Irish healthcare system in both hospital and community settings, but provision of additional funding for new services would enable them to offer a great deal more.

Ecología trófica del pulpo Octopus mimus Gould 1852 (Cephalopoda: Octopodidae) invierno 2013-2014 en la bahía del Callao

El pulpo Octopus mimus es un importante recurso de la pesquería artesanal bentónica, que se distribuye desde el norte del Perú a San Vicente, Chile. Se analizaron contenidos gástricos de 741 ejemplares obtenidos de la captura comercial en la bahía del Callao, durante agosto 2013-agosto 2014. Se determinó que las presas más importantes fueron crustáceos Decapoda: Petrolisthes desmarestii (%FO=24,13; %P=21,29%; N=27,10), Cycloxanthops sexdecimdentatus (%FO=16,35; %P=12,16%; N=15,99) y Allopetrolisthes angulosus (%FO=6,17; %P=6,05; %N=25,20). No hubo diferencias en la dieta entre machos y hembras en %FO y %P (Mann -Whitney U-test, p>0,05). Se observaron diferencias en el IR asociado a las fases de desarrollo gonadal en hembras, ejemplares madurantes/maduros mostraron mayor IR (0,17±0,17) que los desovados (0,08± 0,06), en machos no se observaron diferencias. El IR fue mayor en otoño (0,21±0,17) (Kruskal-Wallis test, p < 0,05). Los índices ecológicos mostraron que O. mimus es un depredador generalista (B’>3), observándose traslapo entre la dieta de machos y hembras (Cλ>0,6), por lo que se concluye que su alimentación está influenciada por una combinación de factores fisiológicos y ambientales.

Revisión del uso de los medicamentos biosimilares vs. biológicos: implicaciones para la salud en Colombia.

Este documento tiene como objetivo describir las implicaciones para la salud con el uso de medicamentos biosimilares en comparación con los medicamentos biológicos en Colombia. Así mismo, describir el contexto normativo acerca del uso de medicamentos biosimilares, las recomendaciones y lineamientos sobre seguridad y efectividad del uso de medicamentos Biosimilares y Biológicos, partiendo de sus diferencias biomoleculares. Para esto, se desarrolló una revisión documental electrónica y manual de la literatura en bases de datos, revistas y libros limitada a términos MeSH. La selección de los artículos incluyo documentos completos publicados en revistas indexadas de los últimos 10 años, en español e inglés; la información recolectada se organizó para la construcción del presente documento. Concluyendo, se encontró que las patentes de muchos medicamentos biológicos han vencido o están próximas a caducar y varios biosimilares están desarrollándose y comercializándose incluso en países sin regulaciones estrictas. Los biosimilares nunca podrán ser iguales al original por su complejidad molecular, por ello debemos integrarlos a los sistemas de farmacovigilancia mejorando trazabilidad e identificando su origen mientras se establecen denominaciones comunes distinguibles. La evidencia actual sugiere que la regulación de medicamentos biosimilares debe ser evaluada y armonizada en todo el mundo.

Acompanhamento farmacoterapêutico de doentes com tuberculose em regime ambulatório

Objectivo: Este estudo tem como objectivo principal a avaliação do impacto do acompanhamento farmacoterapêutico sobre o estado de saúde de doentes com tuberculose (casos novos) em tratamento em regime de ambulatório. Métodos: O estudo incluiu um período de screening com a duração de um mês, seguindo de um período de estudo com a duração de 12 meses. O estudo foi aberto, multicêntrico, randomizado com um grupo de estudo (n=35) e um grupo controlo (n=41). Como metodologia de intervenção foi aplicado uma metodologia baseada num estado de situação do doente e avaliação sistemática de resultados clínicos negativos da medicação. Os dados foram trabalhados em folha de cálculo Microsoft excel2003. Resultados: No grupo de estudo foram efectuadas 665 intervenções farmacêuticas, sobre 490 resultados clínicos negativos da medicação e 175 riscos de resultados clínicos negativos da medicação, de um total de 737 detectados. Houve intervenção sobre 90,23% dos resultados clínicos negativos da medicação, tendo-se resolvido 80,73%. O grupo de estudo teve uma melhor adesão à terapêutica (73,17% no grupo de estudo; 26,83% no grupo controlo) e melhores resultados microbiológicos (p=0,046)), não tendo sido encontradas diferenças estatísticas relativamente aos parâmetros clínicos e radiológicos. Conclusão: O acompanhamento farmacoterapêutico permite detectar, prevenir e resolver resultados clínicos negativos da medicação, resultando assim num impacto positivo sobre o estado de saúde dos doentes com tuberculose em regime de ambulatório. ABSTRACT: Objective: Main objective of this study is to evaluate the impact of medication follow­ up on the health status of patients with tuberculosis (incident cases) in treatment in an ambulatory regimen. Methods: The study included a screening period of one month and then a follow-up period of twelve months. lt was an open study, multicentric, randomized, with a study group (n=35) and a control group (n=41). Intervention consists in a process based on gathering patients’ therapeutic profile and its systematic evaluation of medication negative clinical outcomes. Data were processed in Microsoft Excel 2003 worksheet. Results: ln the study group 665 pharmaceutical interventions on 490 medication negative clinical outcomes due were recorded and 175 risk of negative clinical outcomes, having being detected a total of 737. Pharmacist interventions were done on 90.23% of negative clinical outcomes, resolving 80.73%. The study group had a better therapeutic compliance (73.17% in the study group; 26.83% in the control group) and better microbiological results (p=0.046). However, there were no differences concerning clinical and radiological parameters. Conclusion: Medication follow-up allows detecting, preventing and resolving medication negative clinical outcomes, having a positive impact on tuberculosis patients' health status treated in an ambulatory regimen.

Barreiras e facilitadores à prática do acompanhamento farmacoterapêutico nos serviços farmacêuticos hospitalares portugueses

Objectivos: Identificar e compreender as barreiras e os facilitadores à prática do Acompanhamento Farmacoterapêutico (AFT) nos serviços farmacêuticos hospitalares portugueses. Método: Estudo qualitativo mediante realização de entrevistas semi-estruturadas a farmacêuticos hospitalares com e sem experiência no AFT e análise de conteúdo, retroactiva e temática. Resultados: Estrutura dos serviços farmacêuticos: barreiras (1) falta de tempo, organização das actividades orientadas para a logística, instabilidade dos recursos humanos, barreiras físicas à comunicação, relações em divergência; facilitadores (2) reestruturação, trabalho em equipa. Farmacêutico: (1) resistência à mudança, qualificação inadequada; (2) atitude positiva, legitimação, formação. Meio externo: (1) falta de apoio institucional, relacionamento com o doente, o médico e farmacêutico comunitário, ensino inadequado; (2) apoio institucional, procura do doente, cooperação com o médico e o farmacêutico comunitário, ensino adequado. Tecnologia: (1) acesso aos dados clínicos e a informação, método inadequado; (2) acesso à informação, método adequado, documentação, informatização, marketing, boas práticas. Conclusão: As entrevistas semi-estruturadas fornecerem uma visão ampla, detalhada e pragmática dos potenciais determinantes de uma prática generalizada do AFT nos serviços farmacêuticos hospitalares portugueses. /ABSTRACT: Objectives: To identify and understand the barriers and facilitators for the practice of Medication Therapy Management (MTM) in portuguese’s hospital pharmacy. Method: Qualitative study trough semi-structured interviews with MTM experienced and inexperienced hospital pharmacists followed by retroactive content and thematic analysis. Results: Structure of hospital pharmacy: barriers (1) lack of time, activities focused on logistics, instability of human resources, physical barriers to communication, divergent relationships; facilitators (2) restructuring, teamwork. Pharmacist: (1) resistance to change, inadequate skills, (2) positive attitude, legitimating, formation. Environment: (1) lack of institutional support, relationship with patient, physician and community pharmacist, inadequate teaching, (2) institutional support, patient's demand, cooperation with physician and community pharmacist, appropriate teaching. Technology: (1) lack of access to clinical data and information, inadequate method, (2) access to information, appropriate method, documentation, computerization, marketing, good pharmacy practices. Conclusion: The semi-structured interviews provide a broad, comprehensive and pragmatic view of potential determinants for wide practice of MTM in Portuguese’s hospital pharmacy.